Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Obstructive sleep apnea improves with non-invasive hypoglossal nerve stimulation using temporal interference

F. Missey, MS. Ejneby, I. Ngom, MJ. Donahue, J. Trajlinek, E. Acerbo, B. Botzanowski, AM. Cassarà, E. Neufeld, ED. Glowacki, L. Shangold, WM. Hanes, A. Williamson

. 2023 ; 9 (1) : 18. [pub] 20230809

Status not-indexed Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc23015503

Grant support
834677 "e-NeuroPharma" ERC-2018-ADG European Research Council - International

BACKGROUND: Peripheral nerve stimulation is used in both clinical and fundamental research for therapy and exploration. At present, non-invasive peripheral nerve stimulation still lacks the penetration depth to reach deep nerve targets and the stimulation focality to offer selectivity. It is therefore rarely employed as the primary selected nerve stimulation method. We have previously demonstrated that a new stimulation technique, temporal interference stimulation, can overcome depth and focality issues. METHODS: Here, we implement a novel form of temporal interference, bilateral temporal interference stimulation, for bilateral hypoglossal nerve stimulation in rodents and humans. Pairs of electrodes are placed alongside both hypoglossal nerves to stimulate them synchronously and thus decrease the stimulation amplitude required to activate hypoglossal-nerve-controlled tongue movement. RESULTS: Comparing bilateral temporal interference stimulation with unilateral temporal interference stimulation, we show that it can elicit the same behavioral and electrophysiological responses at a reduced stimulation amplitude. Traditional transcutaneous stimulation evokes no response with equivalent amplitudes of stimulation. CONCLUSIONS: During first-in-man studies, temporal interference stimulation was found to be well-tolerated, and to clinically reduce apnea-hypopnea events in a subgroup of female patients with obstructive sleep apnea. These results suggest a high clinical potential for the use of temporal interference in the treatment of obstructive sleep apnea and other diseases as a safe, effective, and patient-friendly approach. TRIAL REGISTRATION: The protocol was conducted with the agreement of the International Conference on Harmonisation Good Clinical Practice (ICH GCP), applicable United States Code of Federal Regulations (CFR) and followed the approved BRANY IRB File # 22-02-636-1279.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015503
003      
CZ-PrNML
005      
20231020093628.0
007      
ta
008      
231010s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s42234-023-00120-7 $2 doi
035    __
$a (PubMed)37553702
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Missey, Florian $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, 60200, Czech Republic $u Institute de Neurosciences des Systèmes (INS), INSERM, Aix-Marseille Université, Marseille, 13005, France
245    10
$a Obstructive sleep apnea improves with non-invasive hypoglossal nerve stimulation using temporal interference / $c F. Missey, MS. Ejneby, I. Ngom, MJ. Donahue, J. Trajlinek, E. Acerbo, B. Botzanowski, AM. Cassarà, E. Neufeld, ED. Glowacki, L. Shangold, WM. Hanes, A. Williamson
520    9_
$a BACKGROUND: Peripheral nerve stimulation is used in both clinical and fundamental research for therapy and exploration. At present, non-invasive peripheral nerve stimulation still lacks the penetration depth to reach deep nerve targets and the stimulation focality to offer selectivity. It is therefore rarely employed as the primary selected nerve stimulation method. We have previously demonstrated that a new stimulation technique, temporal interference stimulation, can overcome depth and focality issues. METHODS: Here, we implement a novel form of temporal interference, bilateral temporal interference stimulation, for bilateral hypoglossal nerve stimulation in rodents and humans. Pairs of electrodes are placed alongside both hypoglossal nerves to stimulate them synchronously and thus decrease the stimulation amplitude required to activate hypoglossal-nerve-controlled tongue movement. RESULTS: Comparing bilateral temporal interference stimulation with unilateral temporal interference stimulation, we show that it can elicit the same behavioral and electrophysiological responses at a reduced stimulation amplitude. Traditional transcutaneous stimulation evokes no response with equivalent amplitudes of stimulation. CONCLUSIONS: During first-in-man studies, temporal interference stimulation was found to be well-tolerated, and to clinically reduce apnea-hypopnea events in a subgroup of female patients with obstructive sleep apnea. These results suggest a high clinical potential for the use of temporal interference in the treatment of obstructive sleep apnea and other diseases as a safe, effective, and patient-friendly approach. TRIAL REGISTRATION: The protocol was conducted with the agreement of the International Conference on Harmonisation Good Clinical Practice (ICH GCP), applicable United States Code of Federal Regulations (CFR) and followed the approved BRANY IRB File # 22-02-636-1279.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ejneby, Malin Silverå $u Department of Biomedical Engineering, Linköping University, Linköping, 58185, Sweden
700    1_
$a Ngom, Ibrahima $u Institute de Neurosciences des Systèmes (INS), INSERM, Aix-Marseille Université, Marseille, 13005, France
700    1_
$a Donahue, Mary J $u Laboratory of Organic Electronics, Linköping University, Campus Norrköping, Norrköping, 602 21, Sweden
700    1_
$a Trajlinek, Jan $u Central European Institute of Technology, Brno University of Technology, Brno, 61200, Czech Republic
700    1_
$a Acerbo, Emma $u Institute de Neurosciences des Systèmes (INS), INSERM, Aix-Marseille Université, Marseille, 13005, France
700    1_
$a Botzanowski, Boris $u Institute de Neurosciences des Systèmes (INS), INSERM, Aix-Marseille Université, Marseille, 13005, France
700    1_
$a Cassarà, Antonino M $u IT'IS Foundation for Research on Information Technologies in Society, Zurich, 8004, Switzerland
700    1_
$a Neufeld, Esra $u IT'IS Foundation for Research on Information Technologies in Society, Zurich, 8004, Switzerland
700    1_
$a Glowacki, Eric D $u Central European Institute of Technology, Brno University of Technology, Brno, 61200, Czech Republic
700    1_
$a Shangold, Lee $u ENT and Allergy Associates, 1500 Route 112, Port Jefferson Station, New York, 11776, USA
700    1_
$a Hanes, William M $u Somnial Inc, 25 Health Sciences Dr, Stony Brook, New York, USA
700    1_
$a Williamson, Adam $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, 60200, Czech Republic. adam.williamson@fnusa.cz $u Institute de Neurosciences des Systèmes (INS), INSERM, Aix-Marseille Université, Marseille, 13005, France. adam.williamson@fnusa.cz $u Central European Institute of Technology, Brno University of Technology, Brno, 61200, Czech Republic. adam.williamson@fnusa.cz
773    0_
$w MED00205374 $t Bioelectronic medicine $x 2332-8886 $g Roč. 9, č. 1 (2023), s. 18
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37553702 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20231020093622 $b ABA008
999    __
$a ok $b bmc $g 1997165 $s 1201865
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 9 $c 1 $d 18 $e 20230809 $i 2332-8886 $m Bioelectronic medicine $n Bioelectron Med $x MED00205374
GRA    __
$a 834677 "e-NeuroPharma" ERC-2018-ADG $p European Research Council $2 International
LZP    __
$a Pubmed-20231010

Find record

Citation metrics

Archiving options